These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30569481)

  • 1. Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017.
    Bonaldo G; Vaccheri A; D'Annibali O; Motola D
    Br J Clin Pharmacol; 2019 Mar; 85(3):634-643. PubMed ID: 30569481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papilloma virus vaccination in males: A pharmacovigilance study on the Vaccine Adverse Event Reporting System.
    Bonaldo G; Montanaro N; Vaccheri A; Motola D
    Br J Clin Pharmacol; 2021 Apr; 87(4):1912-1917. PubMed ID: 33145777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine.
    Slade BA; Leidel L; Vellozzi C; Woo EJ; Hua W; Sutherland A; Izurieta HS; Ball R; Miller N; Braun MM; Markowitz LE; Iskander J
    JAMA; 2009 Aug; 302(7):750-7. PubMed ID: 19690307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.
    Arana JE; Harrington T; Cano M; Lewis P; Mba-Jonas A; Rongxia L; Stewart B; Markowitz LE; Shimabukuro TT
    Vaccine; 2018 Mar; 36(13):1781-1788. PubMed ID: 29477308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy.
    Scavone C; Di Mauro C; Brusco S; Bertini M; di Mauro G; Rafaniello C; Sportiello L; Rossi F; Capuano A
    Expert Opin Drug Saf; 2019 May; 18(5):427-433. PubMed ID: 30907147
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of the 9-Valent Human Papillomavirus Vaccine.
    Shimabukuro TT; Su JR; Marquez PL; Mba-Jonas A; Arana JE; Cano MV
    Pediatrics; 2019 Dec; 144(6):. PubMed ID: 31740500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System.
    Arana J; Mba-Jonas A; Jankosky C; Lewis P; Moro PL; Shimabukuro TT; Cano M
    J Adolesc Health; 2017 Nov; 61(5):577-582. PubMed ID: 29061232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase
    Chandler RE; Juhlin K; Fransson J; Caster O; Edwards IR; Norén GN
    Drug Saf; 2017 Jan; 40(1):81-90. PubMed ID: 27638661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Events of COVID-19 Vaccines in the United States: Temporal and Spatial Analysis.
    Li Y; Li J; Dang Y; Chen Y; Tao C
    JMIR Public Health Surveill; 2024 Jul; 10():e51007. PubMed ID: 39008362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016.
    Ran J; Yang JY; Lee JH; Kim HJ; Choi JY; Shin JY
    Int J Clin Pharm; 2019 Oct; 41(5):1365-1372. PubMed ID: 31313003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events following immunization in Ontario's female school-based HPV program.
    Harris T; Williams DM; Fediurek J; Scott T; Deeks SL
    Vaccine; 2014 Feb; 32(9):1061-6. PubMed ID: 24440208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the contextual nature of vaccine safety monitoring: Adverse events reporting after HPV-vaccination in Denmark, 2015.
    Schartau S; Heering Holt D; Lützen T; Rytter D; Mølbak K
    Vaccine; 2019 May; 37(19):2580-2585. PubMed ID: 30967312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017.
    Suragh TA; Lewis P; Arana J; Mba-Jonas A; Li R; Stewart B; Shimabukuro TT; Cano M
    Br J Clin Pharmacol; 2018 Dec; 84(12):2928-2932. PubMed ID: 30229993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine.
    Martin D; Menschik D; Bryant-Genevier M; Ball R
    Drug Saf; 2013 Jul; 36(7):547-56. PubMed ID: 23657824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous reports of primary ovarian insufficiency after vaccination: A review of the vaccine adverse event reporting system (VAERS).
    Patricia Wodi A; Marquez P; Mba-Jonas A; Barash F; Nguon K; Moro PL
    Vaccine; 2023 Feb; 41(9):1616-1622. PubMed ID: 36732165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events following HPV vaccination, Alberta 2006-2014.
    Liu XC; Bell CA; Simmonds KA; Svenson LW; Russell ML
    Vaccine; 2016 Apr; 34(15):1800-5. PubMed ID: 26921782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive and in situ cervical cancer reported to the vaccine adverse event reporting system (VAERS).
    Wong C; Krashin J; Rue-Cover A; Saraiya M; Unger E; Calugar A; Markowitz L
    J Womens Health (Larchmt); 2010 Mar; 19(3):365-70. PubMed ID: 20141382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of quadrivalent human papillomavirus vaccine (Gardasil) in pregnancy: adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006-2013.
    Moro PL; Zheteyeva Y; Lewis P; Shi J; Yue X; Museru OI; Broder K
    Vaccine; 2015 Jan; 33(4):519-22. PubMed ID: 25500173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world safety profile of the 9-valent human papillomavirus vaccine: A study in Zhejiang, China from 2019 to 2021.
    Chen F; Pan X; Liang H; Shen L; Wang Y; Chen Y; Lv H; Hu Y
    Hum Vaccin Immunother; 2022 Dec; 18(7):2152256. PubMed ID: 36484114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.